# Re-challenging immune checkpoint inhibitor in a patient with advanced non-small cell lung cancer: a case report

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/re-challenging-immune-checkpoint-inhibitor-in-a-patient-with-advanced-non-small/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Taiki Hakozaki,Yusuke Okuma,Jumpei Kashima |
| Citations | 21 |
| DOI | 10.1186/s12885-018-4212-1 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://bmccancer.biomedcentral.com/counter/pdf/10.1186/s12885-018-4212-1 |
| OpenAlex ID | https://openalex.org/W2801558153 |
| PMID | 29554874 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Jumpei Kashima](https://scholariq.org/researchers/jumpei-kashima/)

## Paper journal

- [BMC Cancer](https://scholariq.org/journals/bmc-cancer/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.